SCARA5 and lung carcinoma: By detection of methylation and gene expression levels in lung cancer tissues, we found the promoter of SCARA5 to be hypermethylated (Figure 2) and SCARA5 protein levels to be decreased (Figure 1I), which is consistent with the database results.